Insiders who reported open-market trades in the last 12 months at the companies David D. Davidar files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Stephen T. Zarrilli - $4.28M in GMED purchases and sales in the last 12 months
Kelly Huller - $3.44M in GMED purchases and sales in the last 12 months
James R. Tobin - $2.24M in GMED purchases and sales in the last 12 months
Kyle Kline - $2.03M in GMED purchases and sales in the last 12 months
Ann D. Rhoads - $818K in GMED purchases and sales in the last 12 months
Leslie V. Norwalk - $558K in GMED purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
David D. Davidar is a corporate insider, tracked as Director of GLOBUS MEDICAL INC (GMED). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David D. Davidar submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has David D. Davidar been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($11.32M) across all tracked filings.
David D. Davidar is Director of GLOBUS MEDICAL INC (GMED). 7 SEC Form 4 filings on record going back to 2024, most recently on 28 July 2026. Most recent open-market trade: sold $2.02M of GMED on 9 June 2026. Lifetime open-market sales: $11.32M.
Recent transactions
12
The latest 12 SEC Form 4 transactions reported by David D. Davidar.
InsiderAlpha's records for David D. Davidar go back to 2024: 7 primary Form 4 filings, an average of 2.3 per year. 6 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
